MGL-IN-1 is a potent and selective irreversible MGL ( β-lactam-based monoacylglycerol lipase ) inhibitor. MGL-IN-1 alleviates symptoms in a MS model in vivo and exhibits analgesic effects in an acute inflammatory pain model in vivo. MGL-IN-1 displays high membrane permeability and brain penetrant.